America’s Looming Health Crisis: The Chronic Disease Epidemic
As chronic disease becomes the norm, Cedrick Wellness Resources is calling for a nutrition-first approach to win the war on...
Cancer
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Canalevia®-CA1 is currently FDA conditionally approved for treatment of CID in dogs and is the first and only treatment for...
G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023
RESEARCH TRIANGLE PARK, N.C., July 26, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will...
Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., July 26, 2023 (GLOBE NEWSWIRE) --...
CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023
BERKELEY HEIGHTS, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
BOCA RATON, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in...
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
LYON, France, July 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
Ocuphire to Present at American Society of Retina Specialists Annual Meeting and OIS Retina Innovation Summit
ASRS presentations will feature data from ZETA-1 Phase 2 trial evaluating APX3330 in diabetic retinopathy End-of-Phase 2 meeting with FDA...
Kincell Bio Launches with $36M to Make Cell Therapy Development and Manufacturing Accessible for Early-Stage Innovators
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies Kincell to be...
Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023
HOUSTON, July 26, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation...
Palette Life Sciences Enters Into Definitive Agreement with Teleflex Incorporated
Acquisition will accelerate global commercial expansion of the company’s product portfolio, including Barrigel® SANTA BARBARA, Calif. and STOCKHOLM, Sweden, July...
Teleflex to Acquire Palette Life Sciences
Acquisition will add Barrigel®, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolioWAYNE, Pa., July 26, 2023 (GLOBE NEWSWIRE)...
Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men’s Health with Participation in Pineapple Healthcare’s “Butt Stuff Brunch with Dr. Carlton”
Napo Medical Affairs Team Member, who is an HIV/Mytesi® (Crofelemer) Patient, to Participate in Educational PanelSAN FRANCISCO, CA / ACCESSWIRE...
SamanTree Medical Appoints New Chief Executive Officer
Histolog® Scanner has been used in 2000 procedures, adoption is acceleratingLAUSANNE, Switzerland--(BUSINESS WIRE)--#medicalimaging--SamanTree Medical, a medical technology company specializing in...
MindBio Therapeutics Begins Recruitment of Participants for World First LSD-Microdosing Clinical Trial in Cancer Patients Experiencing Emotional Distress
World first take-home approvals for LSD-Microdosing in clinical trials in cancer patientsLSD-Microdosing combined with clinically proven Meaning Centred PsychotherapyVANCOUVER, BC...
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
Champions Oncology Reports Quarterly Revenue of $13.1 Million
Record Annual Revenue of $53.9 MillionHACKENSACK, NJ / ACCESSWIRE / July 24, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading...
Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery
SAN FRANCISCO, CA / ACCESSWIRE / July 24, 2023 / A recent peer-reviewed study published in the American Journal of...
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical...